Literature DB >> 30799084

FOXO1 functions in the regulation of nicotinamide phosphoribosyltransferase (Nampt) expression.

Bora Jeong1, Jeong Woo Park1, Jae Geun Kim2, Byung Ju Lee3.   

Abstract

Here, we report that Forkhead Box O1 (FOXO1) protein, a tumor suppressor, regulates expression of nicotinamide phosphoribosyltransferase (Nampt) in human breast cancer MCF-7 cells. Nampt plays an important role in the regulation of cell growth, survival, DNA replication and repair, and angiogenesis in tumorigenesis. We revealed that FOXO1 directly inhibits Nampt expression via binding to FOXO1 binding domains in the 5'-flanking region of the nampt gene. Nampt expression was increased by insulin and downstream phosphatidylinositol 3-kinase (PI3K)/Akt signaling, which was inhibited by FOXO1 overexpression. Accordingly, we showed that FOXO1 is also involved in insulin signaling-induced cell survival and proliferation in MCF-7 cells. These results suggest that FOXO1 plays an important role in human breast cancer cells by regulating nampt gene expression.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; Cell viability; Forkhead Box O1; Nicotinamide phosphoribosyltransferase; Transcriptional regulation

Year:  2019        PMID: 30799084     DOI: 10.1016/j.bbrc.2019.02.069

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Downregulated Copper Homeostasis-Related Gene FOXO1 as a Novel Indicator for the Prognosis and Immune Response of Breast Cancer.

Authors:  Rong Zeng; Bi Peng; Emin Peng
Journal:  J Immunol Res       Date:  2022-06-28       Impact factor: 4.493

2.  NAMPT and NAPRT, Key Enzymes in NAD Salvage Synthesis Pathway, Are of Negative Prognostic Value in Colorectal Cancer.

Authors:  Xiao-Qin Li; Jing Lei; Lin-Hong Mao; Qing-Liang Wang; Feng Xu; Tao Ran; Zhi-Hang Zhou; Song He
Journal:  Front Oncol       Date:  2019-08-06       Impact factor: 6.244

Review 3.  Beyond Energy Metabolism: Exploiting the Additional Roles of NAMPT for Cancer Therapy.

Authors:  Christine M Heske
Journal:  Front Oncol       Date:  2020-01-17       Impact factor: 6.244

Review 4.  Review of various NAMPT inhibitors for the treatment of cancer.

Authors:  Yichen Wei; Haotian Xiang; Wenqiu Zhang
Journal:  Front Pharmacol       Date:  2022-09-07       Impact factor: 5.988

Review 5.  Advances in NAD-Lowering Agents for Cancer Treatment.

Authors:  Moustafa S Ghanem; Fiammetta Monacelli; Alessio Nencioni
Journal:  Nutrients       Date:  2021-05-14       Impact factor: 5.717

6.  The Involvement of Sirtuin 1 Dysfunction in High-Fat Diet-Induced Vascular Dysfunction in Mice.

Authors:  Ning Xia; Gisela Reifenberg; Christian Schirra; Huige Li
Journal:  Antioxidants (Basel)       Date:  2022-03-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.